Pro Vise Management Group, LLC Bristol Myers Squibb CO Transaction History
Pro Vise Management Group, LLC
- $1.17 Billion
- Q2 2024
A detailed history of Pro Vise Management Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 8,419 shares of BMY stock, worth $447,806. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,419
Previous 13,600
38.1%
Holding current value
$447,806
Previous $737,000
52.65%
% of portfolio
0.03%
Previous 0.06%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...